公开(公告)号：EP2953628B1

公开(公告)日：2018-10-10

申请号：EP14709749.7

申请日：2014-02-10

申请人： Glycanova AS

发明人： KRISTIANSEN, Bjørn ,  HOVLAND, Anne, Torill

IPC分类号： A61K31/716 ,  A61K36/07 ,  A61P17/04 ,  A61P17/06

CPC分类号： A61K31/716 ,  A61K9/0014 ,  A61K9/0021 ,  A61K9/06 ,  A61K9/7023 ,  A61K31/728 ,  A61K35/644 ,  A61K36/07 ,  A61K47/06 ,  A61K47/10 ,  A61K47/12 ,  A61K47/26 ,  A61K47/44 ,  A61K2300/00

摘要： The product according to the present invention is produced in a production process using the mycelium of a mushroom such as Ganoderma lucidum. The production process encourages the growing mycelium to export bioactive compounds such as beta glucans into the surrounding liquid. Thus, the beta glucan is soluble and easily absorbed. More importantly, the production process allows the beta glucan to retain its triple helix structure which is required for maintain a very high bioactive efficacy. The beta glucans from Ganoderma lucidum can be used in a cream for treatment of psoriasis.

公开(公告)号：EP1451336B1

公开(公告)日：2019-05-15

申请号：EP02762662.1

申请日：2002-09-03

申请人： Glycanova AS

发明人： KRISTIANSEN, Bjoern ,  WADDELL, David

IPC分类号： C12P19/04 ,  C08B37/00 ,  A61K31/715 ,  A61K36/07 ,  A61K39/00 ,  A61K31/7004 ,  A61K31/716

公开(公告)号：EP2953628A1

公开(公告)日：2015-12-16

申请号：EP14709749.7

申请日：2014-02-10

申请人： Glycanova AS

发明人： KRISTIANSEN, Bjørn ,  HOVLAND, Anne, Torill

IPC分类号： A61K31/716 ,  A61K36/07 ,  A61P17/04 ,  A61P17/06

CPC分类号： A61K31/716 ,  A61K9/0014 ,  A61K9/0021 ,  A61K9/06 ,  A61K9/7023 ,  A61K31/728 ,  A61K35/644 ,  A61K36/07 ,  A61K47/06 ,  A61K47/10 ,  A61K47/12 ,  A61K47/26 ,  A61K47/44 ,  A61K2300/00

摘要： The product according to the present invention is produced in a production process using the mycelium of a mushroom such as Ganoderma lucidum. The production process encourages the growing mycelium to export bioactive compounds such as beta glucans into the surrounding liquid. Thus, the beta glucan is soluble and easily absorbed. More importantly, the production process allows the beta glucan to retain its triple helix structure which is required for maintain a very high bioactive efficacy. The beta glucans from Ganoderma lucidum can be used in a cream for treatment of psoriasis.